APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: T Cell Antigen Gp39Compare research options for T Cell Antigen Gp39

Pharma & Healthcare

Pimozide

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and…

Types
1Mg · 2Mg · 4Mg
Applications
Hospitals · Drugstores · Others

5 editions26 December 2025

View 5 research editions
$4,950Single user · USD · Market Analysis & ForecastExplore product: PimozideCompare research options for Pimozide

Pharma & Healthcare

Circle Acute Ischemic Stroke

Acute ischemic stroke occurs when blood flow through a brain artery is blocked by a clot, a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, the most common of the two, occurs when a clot forms within an artery in the brain.

Types
Thrombolytic Therapeutics · Antihypertensive Therapeutics · Antiplatelet Therapeutics
Applications
Hospitals · Ambulatory Surgical Center · Diagnostic Centers

5 editions21 December 2025

View 5 research editions
APO Research, Inc.